SAN DIEGO, Sept. 21, 2015 /PRNewswire/ -- Sequenom,
Inc. (NASDAQ: SQNM), a life sciences company committed to enabling
healthier lives through the development of innovative products and
services, announced today the appointment of Dirk van den Boom, Ph.D. to the position of
interim President and Chief Executive Officer. Dr. van den Boom succeeds William J. Welch following his resignation from
that role, and as a director, to pursue other interests. In
addition, Dr. van den Boom will
continue to serve as Sequenom's Chief Scientific and Strategy
Officer.
Prior to his appointment as Interim President and CEO, Dr.
van den Boom served as Chief
Scientific and Strategy Officer since June
2014, and before that as Executive Vice President, Research
and Development and Chief Technology Officer beginning in December
2012. Dr. van den Boom joined
Sequenom in 1998 at the Company's Hamburg office, subsequently serving in
various management roles of increasing responsibility.
"We are excited for Dirk to take on the role of interim
President and Chief Executive Officer, and believe that he is well
positioned to lead our key strategic initiatives to develop and
commercialize innovative products and services at Sequenom," said
Kenneth F. Buechler, Ph.D., Chairman
of the Board of Directors. "We are confident that he will
successfully lead our efforts to capitalize on our company's future
growth opportunities and goals. We thank Bill for his efforts
for the Company and wish him well in future endeavors."
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is
committed to enabling healthier lives through the development of
innovative products and services. The Company serves patients and
physicians by providing early patient management information. To
learn how Sequenom is interpreting the genome to improve your life,
visit www.sequenom.com.
Forward-Looking Statements
Statements contained in
this press release regarding matters that are not historical facts
are "forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. Because such statements
are subject to risks and uncertainties, actual results may differ
materially from those expressed or implied by such forward-looking
statements. Risks are described more fully in Sequenom's filings
with the Securities and Exchange Commission, including without
limitation its most recent Annual Report on Form 10-K, its most
recent Quarterly Reports on Form 10-Q, its most recently filed
Current Reports on Form 8-K and other documents subsequently filed
with or furnished to the Securities and Exchange Commission. All
forward-looking statements contained in this press release speak
only as of the date on which they were made. Sequenom undertakes no
obligation to update such statements to reflect events that occur
or circumstances that exist after the date on which they were
made.
![SEQUENOM logo. SEQUENOM logo.](http://photos.prnewswire.com/prnvar/20040415/SQNMLOGO)
Logo - http://photos.prnewswire.com/prnh/20040415/SQNMLOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sequenom-announces-appointment-of-dirk-van-den-boom-as-interim-president-and-ceo-300146038.html
SOURCE Sequenom, Inc.